These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 16330815)

  • 21. Neuropeptide Y modulates effects of bradykinin and prostaglandin E2 on trigeminal nociceptors via activation of the Y1 and Y2 receptors.
    Gibbs JL; Diogenes A; Hargreaves KM
    Br J Pharmacol; 2007 Jan; 150(1):72-9. PubMed ID: 17143304
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neuropeptide Y Y1 receptors mediate morphine-induced reductions of natural killer cell activity.
    Saurer TB; Ijames SG; Lysle DT
    J Neuroimmunol; 2006 Aug; 177(1-2):18-26. PubMed ID: 16766046
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular analysis of central feeding regulation by neuropeptide Y (NPY) neurons with NPY receptor small interfering RNAs (siRNAs).
    Higuchi H
    Neurochem Int; 2012 Nov; 61(6):936-41. PubMed ID: 22414532
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential requirements for Th1 and Th17 responses to a systemic self-antigen.
    Katzman SD; Gallo E; Hoyer KK; Abbas AK
    J Immunol; 2011 Apr; 186(8):4668-73. PubMed ID: 21402892
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neuropeptide Y1 and Y5 receptors mediate the effects of neuropeptide Y on the hypothalamic-pituitary-thyroid axis.
    Fekete C; Sarkar S; Rand WM; Harney JW; Emerson CH; Bianco AC; Beck-Sickinger A; Lechan RM
    Endocrinology; 2002 Dec; 143(12):4513-9. PubMed ID: 12446577
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neuropeptide Y and the retinal pigment epithelium: receptor subtypes, signaling, and bioelectrical responses.
    Ammar DA; Hughes BA; Thompson DA
    Invest Ophthalmol Vis Sci; 1998 Sep; 39(10):1870-8. PubMed ID: 9727410
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neuropeptide Y induced feeding in the rat is mediated by a novel receptor.
    O'Shea D; Morgan DG; Meeran K; Edwards CM; Turton MD; Choi SJ; Heath MM; Gunn I; Taylor GM; Howard JK; Bloom CI; Small CJ; Haddo O; Ma JJ; Callinan W; Smith DM; Ghatei MA; Bloom SR
    Endocrinology; 1997 Jan; 138(1):196-202. PubMed ID: 8977404
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neuropeptide Y induces migration, proliferation, and tube formation of endothelial cells bimodally via Y1, Y2, and Y5 receptors.
    Movafagh S; Hobson JP; Spiegel S; Kleinman HK; Zukowska Z
    FASEB J; 2006 Sep; 20(11):1924-6. PubMed ID: 16891622
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Coexpression of Y1, Y2, and Y4 receptors in smooth muscle coupled to distinct signaling pathways.
    Misra S; Murthy KS; Zhou H; Grider JR
    J Pharmacol Exp Ther; 2004 Dec; 311(3):1154-62. PubMed ID: 15308651
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neuropeptide Y induces ischemic angiogenesis and restores function of ischemic skeletal muscles.
    Lee EW; Michalkiewicz M; Kitlinska J; Kalezic I; Switalska H; Yoo P; Sangkharat A; Ji H; Li L; Michalkiewicz T; Ljubisavljevic M; Johansson H; Grant DS; Zukowska Z
    J Clin Invest; 2003 Jun; 111(12):1853-62. PubMed ID: 12813021
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evidence that the inhibition of luteinizing hormone secretion exerted by central administration of neuropeptide Y (NPY) in the rat is predominantly mediated by the NPY-Y5 receptor subtype.
    Raposinho PD; Broqua P; Pierroz DD; Hayward A; Dumont Y; Quirion R; Junien JL; Aubert ML
    Endocrinology; 1999 Sep; 140(9):4046-55. PubMed ID: 10465275
    [TBL] [Abstract][Full Text] [Related]  

  • 32. NPY and Y receptors: lessons from transgenic and knockout models.
    Lin S; Boey D; Herzog H
    Neuropeptides; 2004 Aug; 38(4):189-200. PubMed ID: 15337371
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Y1 receptors are critical for the proliferation of adult mouse precursor cells in the olfactory neuroepithelium.
    Doyle KL; Karl T; Hort Y; Duffy L; Shine J; Herzog H
    J Neurochem; 2008 May; 105(3):641-52. PubMed ID: 18088353
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neuropeptide Y (NPY) inhibits spontaneous contraction of the mouse atrium by possible activation of the NPY1 receptor.
    Oki Y; Teraoka H; Kitazawa T
    Auton Autacoid Pharmacol; 2017 Mar; 37(2):23-28. PubMed ID: 28544313
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of neuropeptide Y receptors mRNA and protein in human brain vessels and cerebromicrovascular cells in culture.
    Abounader R; Elhusseiny A; Cohen Z; Olivier A; Stanimirovic D; Quirion R; Hamel E
    J Cereb Blood Flow Metab; 1999 Feb; 19(2):155-63. PubMed ID: 10027771
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Subtypes Y1 and Y2 of the neuropeptide Y receptor are respectively expressed in pro-opiomelanocortin- and neuropeptide-Y-containing neurons of the rat hypothalamic arcuate nucleus.
    Broberger C; Landry M; Wong H; Walsh JN; Hökfelt T
    Neuroendocrinology; 1997 Dec; 66(6):393-408. PubMed ID: 9430445
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Greater bone formation of Y2 knockout mice is associated with increased osteoprogenitor numbers and altered Y1 receptor expression.
    Lundberg P; Allison SJ; Lee NJ; Baldock PA; Brouard N; Rost S; Enriquez RF; Sainsbury A; Lamghari M; Simmons P; Eisman JA; Gardiner EM; Herzog H
    J Biol Chem; 2007 Jun; 282(26):19082-91. PubMed ID: 17491022
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Co-expression of neuropeptide Y Y1 and Y5 receptors results in heterodimerization and altered functional properties.
    Gehlert DR; Schober DA; Morin M; Berglund MM
    Biochem Pharmacol; 2007 Dec; 74(11):1652-64. PubMed ID: 17897631
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of axotomy on expression of NPY, galanin, and NPY Y1 and Y2 receptors in dorsal root ganglia and the superior cervical ganglion studied with double-labeling in situ hybridization and immunohistochemistry.
    Landry M; Holmberg K; Zhang X; Hökfelt T
    Exp Neurol; 2000 Apr; 162(2):361-84. PubMed ID: 10739642
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neuropeptide Y attenuates NMDA-induced phase shifts in the SCN of NPY Y1 receptor knockout mice in vitro.
    Soscia SJ; Harrington ME
    Brain Res; 2004 Oct; 1023(1):148-53. PubMed ID: 15364030
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.